JP2005525895A5

JP2005525895A5 -

Info

Publication number: JP2005525895A5
Application number: JP2004505968A
Authority: JP
Filing date: 2003-05-02
Publication date: 2006-06-22

Claims

A method for marking a product and / or packaging or repackaging comprising:
1) At least one originality component, wherein the product and / or packaging or repackaging comprises at least one non-encrypted form (A) individual identifier and at least one encrypted form (B) individual identifier It is marked by
2) This unencrypted identifier (A) includes at least one individual identification number and possibly further one or more features;
3) The above method wherein the encrypted identifier (B) is created from the contents of the unencrypted identifier (A), and 4) the originality component is provided in a plain text or machine readable manner.

The product is a pharmaceutical or cosmetic product, preferably a blood bank, blister pack, ampoule, vial, syringe, tablet, capsule, cachet, troche, plaster, and / or their packaging or repackaging The method of claim 1, wherein:

Further features
1) Article number, preferably PZN, EAN (European Article Number), UPC (Universal Product Code), NDC (National Drug Code), or NHRIC (National Health Related Item Code), and / or 2) Batch number, and / or Or 3) the date of manufacture, and / or 4) the expiration date, and / or 5) the identifier for packaging or repackaging, and / or 6) any other number for marking the product, or 2. The method according to 2.

4. A method according to any one of claims 1 to 3, wherein the individual identification number is generated from an article number, preferably PZN, a batch number and / or a serial number in the batch.

The originality component is a one-dimensional code, preferably code 39, extended code 39 or code 128, and / or a two-dimensional code, preferably 3D barcode, 3-DI, array tag, aztec code, small aztec code, coder block , Code 1, Code 16K, Code 49, CP code, Data glyphs, Data matrix code, Data strip code, Dot code A, Hugh code, Maxi code, Mini code, PDF417, Micro PDF417, QR code, Smart code, Snowflake The method according to claim 1, wherein the method is a cord, a super code, or an ultra code.

The method according to claim 1, wherein the originality component is a data matrix code.

The method according to claim 1, wherein the encryption identifier (B) is created from the content of the non-encryption identifier (A) using an asymmetric encryption method.

The method according to claim 1, wherein the asymmetric encryption method is an RSA method.

A product marked according to the method of any of claims 1-8.

10. Product according to claim 9, characterized in that the product is a pharmaceutical or a cosmetic.

The product is a pharmaceutical or cosmetic product, preferably a blood bank, blister pack, ampoule, vial, syringe, tablet, capsule, cachet, troche, plaster, tube, inhalant, spray bottle The product according to claim 9 or 10.

Packaging or repackaging marked according to the method of any of claims 1-8.

Packaging or repackaging according to claim 12, characterized in that the packaging, repackaging or combination of packaging comprises pharmaceuticals or cosmetics.

A method for detecting contamination of a product,
1) the product is marked with at least one originality component comprising at least one non-encrypted (A) individual identifier;
This individual identifier (A) is encrypted in the encrypted form (B) using the secret key of the asymmetric encryption method,
This product is marked with individual identifiers in unencrypted form (A) and encrypted form (B), and possibly further features,
This encryption identifier (B) is created from the contents of the non-encryption identifier (A),
And this originality component is made in plain text or machine readable form,
2) The originality component of the product has been read by the buyer or trader, and the encrypted individual identifier (B) has been decrypted using the public key associated with the asymmetric encryption secret key;
3) The method as described above, wherein the information from the decrypted individual identifier is compared with the unencrypted identifier.

13. A method according to claim 12, wherein the product is a pharmaceutical or cosmetic product.

The product is a pharmaceutical or cosmetic product, preferably a blood bank, blister pack, ampoule, vial, syringe, tablet, capsule, cachet, troche, plaster,
14. A method according to claim 12 or 13, which is and / or packaging or repackaging thereof.

Further features
1) Article number, preferably PZN, EAN (European Article Number), UPC (Universal Product Code), NDC (National Drug Code), or NHRIC (National Health Related Item Code), and / or 2) Batch number, and / or Or 3) the date of manufacture, and / or 4) the expiration date, and / or 5) the identifier for packaging or repackaging, and / or 6) any other number for marking the product. 14. The method according to any one of 14.

16. A method according to any of claims 12-15, wherein the individual identification number is created from an article number, preferably PZN, a batch number and a serial number in the batch.

The originality component is one-dimensional code, preferably code 39, extended code 39 or code 128, or two-dimensional code, preferably 3D barcode, 3-DI, array tag, aztec code, small aztec code, coder block, code 1, code 16K, code 49, CP code, data glyphs, data matrix code, data strip code, dot code A, Hugh code, maxi code, mini code, PDF417, micro PDF417, QR code, smart code, snowflake code, The method according to any one of claims 12 to 16, which is a super code or an ultra code.

20. A method according to any one of claims 14 to 19, wherein the originality component is a data matrix code.